ccc_R08 is an orally available HBV cccDNA inhibitor that reduces extracellular levels of HBV DNA, HBsAg, and HBeAg in a dose-dependent manner. ccc_R08 is investigational for use in the treatment of HBV infections. ccc_R08 has been shown to be effective in the treatment of hepatitis C virus (HCV).
Molecular Weight:
414.84
Purity:
99.86%
CAS Number:
[2919019-72-8]
Formula:
C22H19ClO6
Target:
HBV
T73440
* VAT and and shipping costs not included. Errors and price changes excepted